Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Broglio

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Journal of Endocrinological Investigation|April 9, 1999
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humansE Arvat, L Di Vito, F Lanfranco, et al.
Journal of Endocrinological Investigation|February 24, 2001
Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3)R Granata, F Broglio, D Migliorino, et al.
Journal of Endocrinological Investigation|July 5, 2003
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of deliveryS Bellone, A Rapa, D Vivenza, et al.
Diabetes & Metabolism|May 19, 2018
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-upV Ponzo, L Gentile, R Gambino, et al.
Clinical Endocrinology|February 21, 2006
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese childrenR Baldelli, S Bellone, N Castellino, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humansE Ghigo, L Gianotti, E Arvat, et al.
Clinical Endocrinology|April 24, 2004
Circulating ghrelin levels in the newborn are positively associated with gestational ageS Bellone, A Rapa, D Vivenza, et al.
European Journal of Heart Failure|April 18, 2002
GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathyM Imazio, M Bobbio, F Broglio, et al.
Journal of Endocrinological Investigation|January 9, 2023
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective studyM L Morieri, I Raz, A Consoli, et al.
Journal of Endocrinological Investigation|April 4, 2002
Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiencyL Gianotti, M Stella, D Bollero, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Journal of Endocrinological Investigation|April 9, 1999
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humansE Arvat, L Di Vito, F Lanfranco, et al.
Journal of Endocrinological Investigation|February 24, 2001
Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3)R Granata, F Broglio, D Migliorino, et al.
Journal of Endocrinological Investigation|July 5, 2003
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of deliveryS Bellone, A Rapa, D Vivenza, et al.
Diabetes & Metabolism|May 19, 2018
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-upV Ponzo, L Gentile, R Gambino, et al.
Clinical Endocrinology|February 21, 2006
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese childrenR Baldelli, S Bellone, N Castellino, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humansE Ghigo, L Gianotti, E Arvat, et al.
Clinical Endocrinology|April 24, 2004
Circulating ghrelin levels in the newborn are positively associated with gestational ageS Bellone, A Rapa, D Vivenza, et al.
European Journal of Heart Failure|April 18, 2002
GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathyM Imazio, M Bobbio, F Broglio, et al.
Journal of Endocrinological Investigation|January 9, 2023
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective studyM L Morieri, I Raz, A Consoli, et al.
Journal of Endocrinological Investigation|April 4, 2002
Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiencyL Gianotti, M Stella, D Bollero, et al.
Pageof 11